Unknown

Dataset Information

0

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Fang W 

PROVIDER: S-EPMC7901210 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

Fang Wenfeng W   Jin Haoxuan H   Zhou Huaqiang H   Hong Shaodong S   Ma Yuxiang Y   Zhang Yaxiong Y   Su Xiaofan X   Chen Longyun L   Yang Yunpeng Y   Xu Shengqiang S   Liao Yuwei Y   He Yuming Y   Zhao Hongyun H   Huang Yan Y   Gao Zhibo Z   Zhang Li L  

Molecular cancer 20210223 1

Similar Datasets

Unknown DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.
| S-EPMC6068455 | biostudies-literature
Unknown Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer.
| S-EPMC6299138 | biostudies-literature
Unknown RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer.
| S-EPMC7230458 | biostudies-literature
Unknown Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer.
| S-EPMC8636618 | biostudies-literature
Unknown Biomarker-Targeted Therapies in Non-Small Cell Lung Cancer: Current Status and Perspectives.
| S-EPMC9600447 | biostudies-literature
Unknown Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer.
| S-EPMC7531287 | biostudies-literature
Unknown PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer.
| S-EPMC10920108 | biostudies-literature
Unknown Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
| S-EPMC7476088 | biostudies-literature
Unknown Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
| S-EPMC8109255 | biostudies-literature
Unknown Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
| S-EPMC4941982 | biostudies-literature